| Literature DB >> 35962025 |
Awoke Seyoum Tegegne1, Melkamu A Zeru2.
Abstract
The rate of prevalence of HIV among adults has been increasing in sub-Saharan African countries over the last decade. The objective of this study was to evaluate the interventions on HIV case management based on cART adherence and disclosure of HIV disease status among HIV-positive adults under treatment. A retrospective cohort longitudinal data was conducted on 792 randomly selected patients in the study area. Engagement of HIV-positive persons into care and achieving treatment outcomes such as the disclosure of HIV status and cART adherence were fundamental for HIV prevention strategy. The two response variables under the current investigation were evaluation of intervention on HIV case management interims cART adherence and disclosure of HIV status. Binary logistic regression was conducted for separate models. Among the predictors, age of patients (AOR = 1.020, 95% CI (1.016, 1.191); p value = 0.005), the number of follow-up (AOR = 1.014, 95% CI (1.023, 1.030); p value < 0.0001). CD4 cell count (AOR = 0.981; 95% CI (0.765, 0.971), p value < 0.01), Marital status (AOR = 1.013; 95% CI (1.002, 1.015), p value = 0.006), female patients (AOR = 1.014; 95% CI (1.001, 1.121), p value < 0.007), rural (AOR = 0.982; 95% CI (0.665, 0.998), p value = 0.004), non-educated adult patients (AOR = 0.950, 95% CI (0.92. 0.98). p value = 0.003), Non-existence of social violence (AOR = 1.012, 95% CI (1.008, 1.234), p value < 0.01), adult with non-opportunistic diseases (AOR = 1.021, 95% CI (1.002. 1.042). p value = 0.001) significantly affected the two response variables jointly. Interventions on HIV case management lead to an efficient continuum of successful treatment outcomes like disclosure of HIV status and cART adherence. Hence, HIV case management intervention and the two results had a positive association. HIV case management intervention should be given to younger patients, rural residents, and non-educated patients to disclose the disease status and to have a long life with the virus. Health-related education should be conducted for the community in general and for patients in particular on how HIV is transferred from an infected person to an uninfected one. This helps to reduce the stigma of patients and to deliver social support to patients.Entities:
Mesh:
Year: 2022 PMID: 35962025 PMCID: PMC9374750 DOI: 10.1038/s41598-022-17905-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Baseline socio-demographic, economic and clinical variables (n = 792).
| Variables | Average | No (%) |
|---|---|---|
| Weight (kg) | 58.1 (45–70) | – |
| Base line CD4 cells/mm3 | 148.7 (113–180) | – |
| Age (years) | 74.3 (48–78) | – |
| Follow-up times | 23 visits | – |
| First month/initial CD4 cell count change/mm3 | 16.6 (12–26) | – |
| Male | 392 (49.4) | |
| Female | 400 (50.6) | |
| Non-educated | 163 (20.6) | |
| Educated | 629 (79.4) | |
| Urban | 468 (59.1) | |
| Rural | 324 (40.9) | |
| Living with partner | 446 (56.3) | |
| Living without Partner | 346 (43.7) | |
| Yes | 164(20.7) | |
| No | 628(79.3) | |
| Yes | 426(53.8) | |
| No | 366(46.2) | |
| Yes | 375(47.3) | |
| No | 417(52.7) | |
| Stage I | 101 (12.8) | |
| Stage II | 259 (32.7) | |
| Stage III | 199 (25.1) | |
| Stage IV | 233 (29.4) | |
| Yes | 166 (21.0) | |
| No | 426 (79.0) | |
| Yes | 390 (49.2) | |
| No | 402 (50.8) | |
| Adherent | 202 (25.5) | |
| Non-adherent | 590 (74.5) | |
Parameter estimates for marginal models of disclosure of HIV status and adherence to cART.
| Variables | Disclosure of HIV status | Adherence to cART | ||||
|---|---|---|---|---|---|---|
| Estimates | St. error | p value | Estimates | St. error | p value | |
| Intercept | 3.014 | 0.703 | < 0.01* | 0.922 | 0.245 | < 0.01* |
| Age | 0.022 | 0.611 | 0.003* | 0.122 | 0.013 | < 0.01* |
| Weight | − 0.023 | 0.814 | 0.001* | 0.031 | 0.016 | < 0.01* |
| Baseline CD4 cell count | 0.011 | 1.413 | < 0.001* | 0.022 | 0.014 | < 0.01* |
| Number of follow-ups | 0.032 | 0.943 | < 0.001* | 0.033 | 1.038 | < 0.01* |
| With partners | 0.023 | 1.603 | 0.005* | − 0.012 | 0.051 | 0.021* |
| Sex (Ref. = male) | ||||||
| Female | 0.015 | 0.713 | < 0.001 | 0.014 | 1.104 | < 0.001* |
| No | 0.046 | 1.435 | < 0.01* | − 0.132 | 1.023 | 0.002* |
| No | − 0.031 | 0.763 | 0.002* | − 0.031 | 0.231 | 0.031* |
| No | 0.021 | 0.923 | 0.013* | 0.021 | 0.231 | 0.003* |
| Rural | − 0.016 | 0.921 | 0.046* | − 0.135 | 1.432 | 0.148 |
| Non-educated | − 0.024 | 0.814 | < 0.021* | − 0.125 | 0.156 | 0.512* |
| Yes | − 0.035 | 1.906 | < 0.018* | 0.725 | 1.091 | < 0.014* |
| Stage I | − 0.138 | 0.818 | < 0.016* | − 0.194 | 1.013 | 0.072 |
| Stage II | − 0.142 | 1.916 | < 0.073 | 0.246 | 0.092 | 0.026 |
| Stage III | − 0.19 | 1.715 | < 0.059 | 0.158 | 0.096 | 0.094 |
*significant at 5% level of confidence.
Parameter estimates for conditional independence of random intercepts model with disclosure of HIV status data and adherence to cRRT data.
| Parameter | Disclosure of HIV status | Adherence to cART | ||||
|---|---|---|---|---|---|---|
| Estimates | St. error | p value | Estimates | St. error | p value | |
| Intercept | 3.014 | 0.003 | < 0.01* | 0.922 | 0.245 | < 0.001* |
| Age | 0.025 | 0.011 | 0.003* | 0.122 | 0.013 | < 0.001* |
| Weight | − 0.021 | 0.014 | 0.001* | 0.031 | 0.016 | 0.001* |
| Baseline CD4 cell count | 0.014 | 0.013 | < 0.001* | 0.022 | 0.014 | < 0.001* |
| Number of follow-ups | 0.032 | 0.043 | < 0.001* | 0.033 | 0.038 | 0.012* |
| With partners | 0.023 | 0.035 | 0.005* | − 0.012 | 0.051 | 0.021* |
| Sex (Ref. = Male | ||||||
| Female | 0.01 | 0.016 | < 0.001 | 0.014 | 0.104 | < 0.001 |
| No | 0.046 | 0.435 | < 0.001 | − 0.132 | 0.023 | 0.002* |
| No | − 0.031 | 0.763 | 0.002 | − 0.031 | 0.231 | 0.031* |
| No | 0.021 | 0.923 | 0.013 | 0.021 | 0.231 | 0.003* |
| Rural | − 0.015 | 0.016 | 0.045* | 0.134 | 0.013 | 0.014 |
| Non-educated | − 0.026 | 0.015 | < 0.012* | − 0.125 | 0.154 | 0.012* |
| Yes | − 0.034 | 0.204 | < 0.013* | 0.725 | 0.091 | < 0.013* |
| Stage I | 0.137 | 0.015 | < 0.014* | − 0.192 | 0.013 | 0.072 |
| Stage II | 0.146 | 0.016 | < 0.041 | 0.246 | 0.094 | 0.025 |
| Stage III | 0.104 | 0.014 | < 0.015* | 0.156 | 0.092 | 0.092 |
*Significant at 95% CI for both outcomes.
Parameter estimates for disclosure of HIV status data using a linear predictor.
| Parameter | Estimates | St. error | Adjusted odds ratio (AOR) | Wald 95% CI | p value | |
|---|---|---|---|---|---|---|
| Intercept | 3.011 | 0.037 | 20.29 | 51.53 | 58.62 | < 0.001* |
| Age | 0.022 | 0.267 | 1.020 | 1.016 | 1.19 | 0.005* |
| Weight | − 0.026 | 0.865 | 1.024 | 0.015 | 1.01 | 0.082 |
| Baseline CD4 cell count | − 0.023 | 0.764 | 0.981 | 0.765 | 0.97 | < 0.001* |
| Follow-up times | 0.014 | 0.517 | 1.014 | 1.023 | 1.03 | < 0.001* |
| With partners | 0.011 | 0.715 | 1.013 | 1.002 | 1.015 | 0.006 |
| Female | 0.014 | 0.453 | 1.014 | 0.015 | 1.02 | 0.007 |
| No | 0.046 | 0.435 | 1.041 | 1.001 | 1.121 | < 0.001* |
| No | − 0.034 | 0.546 | 0.970 | 0.765 | 0.998 | < 0.001* |
| No | 0.011 | 0.462 | 1.010 | 1.001 | 1.131 | 0.001* |
| No | 0.021 | 0.082 | 1.021 | 1.002 | 1.042 | 0.001* |
| Rural | − 0.021 | 0.011 | 0.982 | 0.965 | 0.998 | 0.004* |
| Non-educated | − 0.052 | 0.012 | 0.951 | 0.924 | 0.987 | 0.003* |
| Middle income | − 0.01 | 0.013 | 0.991 | 0.015 | 1.012 | 0.006 |
| Low income | − 0.014 | 0.006 | 0.992 | 0.986 | 1.102 | 0.103 |
| No | − 0.024 | 0.307 | 0.982 | 0.525 | 0.997 | < 0.001* |
| Adherent | 0.063 | 0.514 | 1.065 | 1.061 | 1.073 | < 0.001* |
| Stage I | 0.124 | 0.013 | 1.136 | 1.123 | 1.142 | 0.062 |
| Stage II | 0.123 | 0.012 | 1.132 | 1.124 | 1.052 | 0.061 |
| Stage III | 0.102 | 0.043 | 1.118 | 0.092 | 1.103 | 0.093 |
*Significant at 95% CI for both outcomes, = AOR.